FNY Investment Advisers’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-272
Closed -$2K 1455
2025
Q3
$2K Sell
272
-705
-72% -$5.5K ﹤0.01% 1080
2025
Q2
$8K Buy
+977
New +$7.08K ﹤0.01% 695
2023
Q2
Sell
-105
Closed -$2K 696
2023
Q1
$2K Buy
+105
New +$2.81K ﹤0.01% 486

Other funds holding TDOC

FNY Investment Advisers's TDOC Position: Q4 2025 in Review

FNY Investment Advisers sold out of Teladoc Health (TDOC) in Q4 2025, closing a stake of 7,624 shares — an estimated $58K sold.

FNY Investment Advisers first reported a position in TDOC in Q1 2021 and held it in 16 quarters. The position peaked at $1.51M in Q4 2021. 345 funds tracked by Wall St. Rank hold TDOC as of Q4 2025.

  • FNY Investment Advisers reported no remaining Teladoc Health position as of Q4 2025 after selling out during the quarter.
  • FNY Investment Advisers sold 7,624 Teladoc Health shares in Q4 2025, an estimated $58K.
  • FNY Investment Advisers first reported a position in Teladoc Health in Q1 2021 and held it in 16 quarters.
  • FNY Investment Advisers's Teladoc Health position peaked at $1.51M in Q4 2021.
  • 345 funds tracked by Wall St. Rank held Teladoc Health as of Q4 2025.

Based on FNY Investment Advisers's 13F filing for Q4 2025, filed 16 Jan 2026.